Mirae Asset Global Investments
SCPH

Mirae Asset Global Investments’s scPharmaceuticals SCPH Stock Holding History

Mirae Asset Global Investments’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,061
Closed -$11.7K – 1733
2025
Q3 		$11.7K Buy
2,061
+22
+1% +$113 ﹤0.01% 1556
2025
Q2 		$7.77K Buy
2,039
+365
+22% +$1.13K ﹤0.01% 1520
2025
Q1 		$4.64K Buy
1,674
+6
+0.4% +$20 ﹤0.01% 1517
2024
Q4 		$5.71K Buy
+1,668
New +$6.39K ﹤0.01% 1552
2024
Q1 		– Sell
-14,884
Closed -$93.3K – 2624
2023
Q4 		$93.3K Hold
14,884
– – ﹤0.01% 2477
2023
Q3 		$106K Hold
14,884
– – ﹤0.01% 2450
2023
Q2 		$152K Buy
+14,884
New +$155K ﹤0.01% 2419

Mirae Asset Global Investments's SCPH Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 2,061 shares — an estimated $11.7K sold.

Mirae Asset Global Investments first reported a position in SCPH in Q2 2023 and held it in 7 quarters. The position peaked at $152K in Q2 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,061 scPharmaceuticals shares in Q4 2025, an estimated $11.7K.
  • Mirae Asset Global Investments first reported a position in scPharmaceuticals in Q2 2023 and held it in 7 quarters.
  • Mirae Asset Global Investments's scPharmaceuticals position peaked at $152K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.